Lexicon Pharmaceuticals (LXRX) Reports Q1 EPS In-Line, Misses Revenue Estimate
Tweet Send to a Friend
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) reports a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
